Cyient DLM presents its investor presentation for Q3 FY26, highlighting key EMS trends, strategic initiatives, and financial performance. The company reports a revenue of ₹3,033 Mn and a normalized EBITDA of ₹309 Mn. Despite revenue headwinds, EBITDA margins remained stable, demonstrating operational resilience. The company is focused on strengthening its market presence and diversifying its customer portfolio.
Key Business Highlights
Cyient DLM continues to focus on strategic growth and operational excellence. Key highlights from Q3 FY26 include:
- Recognized as Best Performer for Electronic Hardware Exports by Software Technologies Parks of India for FY24-25.
- Received Risk Mitigation Award from an Aero customer for delivering a reliable PCBA Program.
- Diversifying the customer portfolio with 2 new logos in the medical and industrial sectors.
- Commenced revenue realization from B2S, with expectations for significant scale-up in the coming periods.
Strategic Initiatives
Cyient DLM is focused on several key strategic initiatives to drive future growth:
- Strengthening go-to-market strategies by building a strong sales team and focusing on acquiring new logos.
- Building operational excellence through automation, digitization, and investments in technology.
- Expanding B2S and Platform Play by investing in people, capabilities, and technology.
- Focusing on new markets and capability acquisition, particularly in Europe and the global defense business.
Financial Performance
The consolidated financial results for Q3 FY26 are as follows:
- Revenue: ₹3,033 Mn (down 31.7% YoY)
- Normalized EBITDA: ₹309 Mn (down 14.4% YoY)
- Reported EBITDA: ₹275 Mn (down 1.6% YoY)
- Normalized PAT: ₹138 Mn (down 18.6% YoY)
- Reported PAT: ₹112 Mn (up 1.9% YoY)
- Order Backlog: ₹23,494 Mn
Despite a decline in revenue due to large order completion in FY25, EBITDA margins remained stable, demonstrating strong operational resilience. Normalized EBITDA margin stood at 10.2%, and Reported PAT margin was 3.7%.
Revenue Share Breakdown
- Industry: Aerospace (37%), Defence (16%), Industrial (30%), Med Tech & Others (8%)
- Product Category: PCBA (51%), Box Build (22%), Cables (25%), Mech & Others (2%)
- Mix: India (14%), Rest of World (86%)
The PCBA share continues to be dominant. The company is focusing on strengthening both Industrial and Med-Tech segments.
Source: BSE
